Skip to main content
Livermore
Livermore
ZHEN

Van Eck Associates Corp

SEC CIK
0000869178
Latest filing
Aug 14, 2026

TXG holding history

10x Genomics, Inc. in every 13F filed by Van Eck Associates Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TXG overviewAll 13F holders of TXGFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of TXG by Van Eck Associates Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−3,903−100.0%Sold outHolders
Q1 20263,903$83.0K<0.1%+235+6.4%AddedHolders
Q4 20253,668$60.0K<0.1%+1,695+85.9%AddedHolders
Q3 20251,973$23.0K<0.1%+703+55.4%AddedHolders
Q2 20251,270$15.0K<0.1%00.0%UnchangedHolders
Q1 20251,270$11.0K<0.1%00.0%UnchangedHolders
Q4 20241,270$18.0K<0.1%−114−8.2%ReducedHolders
Q3 20241,384$21.0K<0.1%−738−34.8%ReducedHolders
Q2 20242,122$41.0K<0.1%−111−5.0%ReducedHolders
Q1 20242,233$84.0K<0.1%+325+17.0%AddedHolders
Q4 20231,908$107.0K<0.1%+362+23.4%AddedHolders
Q3 20231,546$64.0K<0.1%+125+8.8%AddedHolders
Q2 20231,421$79.0K<0.1%−211−12.9%ReducedHolders
Q1 20231,632$91.0K<0.1%+107+7.0%AddedHolders
Q4 20221,525$56.0K<0.1%+200+15.1%AddedHolders
Q3 20221,325$38.0K<0.1%−86,854−98.5%ReducedHolders
Q2 202288,179$3.99M<0.1%+9,124+11.5%AddedHolders
Q1 202279,055$6.01M<0.1%+16,364+26.1%AddedHolders
Q4 202162,691$9.34M<0.1%−2,091−3.2%ReducedHolders
Q3 202164,782$9.43M<0.1%−19,701−23.3%ReducedHolders
Q2 202184,483$16.5M<0.1%−6,798−7.4%ReducedHolders
Q1 202191,281$16.5M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.